| Brian Vold Arnp Plc | |
|
814 Railroad St Iowa Falls IA 50126-2113 | |
| (641) 648-4010 | |
| Not Available |
| Full Name | Brian Vold Arnp Plc |
|---|---|
| Speciality | Clinic/Center |
| Location | 814 Railroad St, Iowa Falls, Iowa |
| Authorized Official Name and Position | Brian S Vold (OWNER) |
| Authorized Official Contact | 6414200217 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Brian Vold Arnp Plc 1239 Cerro Gordo St Sheffield IA 50475-8123 Ph: (641) 420-0217 | Brian Vold Arnp Plc 814 Railroad St Iowa Falls IA 50126-2113 Ph: (641) 648-4010 |
| NPI Number | 1134670532 |
|---|---|
| Provider Enumeration Date | 10/20/2016 |
| Last Update Date | 10/20/2016 |
| Medicare PECOS PAC ID | 7214218734 |
|---|---|
| Medicare Enrollment ID | O20161221001091 |
News Archive
In the current issue of Psychotherapy and Psychosomatics a randomized controlled trial indicates that group therapy may affect the course of bipolar disorder. This study evaluated the effectiveness of adjunctive cognitive behavioral group therapy to prevent recurrence of episodes in 50 euthymic patients with bipolar disorder types I and II followed up for at least 12 months in an outpatient service and whose disease was in remission.
Cerus Corporation announced today that it has entered into a $30 million growth capital credit facility with Oxford Finance LLC.
mPhase Technologies, Inc. announced today that their Phase II STTR Grant was renewed by the U.S. Army. The two year grant was initially awarded in September 2008 for the amount of $750,000. mPhase will continue to develop the Smart NanoBattery under this grant program through September 2010.
The U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Humira (adalimumab) for multiple inflammatory diseases.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134670532 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM0801X | Clinic/center - Mental Health (including Community Mental Health Center) | G127881 (Iowa) | Primary |
| Provider Name | Brian S Vold |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1285047951 PECOS PAC ID: 9436374634 Enrollment ID: I20140701002683 |
News Archive
In the current issue of Psychotherapy and Psychosomatics a randomized controlled trial indicates that group therapy may affect the course of bipolar disorder. This study evaluated the effectiveness of adjunctive cognitive behavioral group therapy to prevent recurrence of episodes in 50 euthymic patients with bipolar disorder types I and II followed up for at least 12 months in an outpatient service and whose disease was in remission.
Cerus Corporation announced today that it has entered into a $30 million growth capital credit facility with Oxford Finance LLC.
mPhase Technologies, Inc. announced today that their Phase II STTR Grant was renewed by the U.S. Army. The two year grant was initially awarded in September 2008 for the amount of $750,000. mPhase will continue to develop the Smart NanoBattery under this grant program through September 2010.
The U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Humira (adalimumab) for multiple inflammatory diseases.
› Verified 1 days ago
News Archive
In the current issue of Psychotherapy and Psychosomatics a randomized controlled trial indicates that group therapy may affect the course of bipolar disorder. This study evaluated the effectiveness of adjunctive cognitive behavioral group therapy to prevent recurrence of episodes in 50 euthymic patients with bipolar disorder types I and II followed up for at least 12 months in an outpatient service and whose disease was in remission.
Cerus Corporation announced today that it has entered into a $30 million growth capital credit facility with Oxford Finance LLC.
mPhase Technologies, Inc. announced today that their Phase II STTR Grant was renewed by the U.S. Army. The two year grant was initially awarded in September 2008 for the amount of $750,000. mPhase will continue to develop the Smart NanoBattery under this grant program through September 2010.
The U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Humira (adalimumab) for multiple inflammatory diseases.
› Verified 1 days ago
Achieve Mental Health, Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 814 Railroad St, Iowa Falls, IA 50126 Phone: 641-648-4010 Fax: 186-630-9419 | |
Emh Physicians Clinic Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 520 Talbott St Ste 3, Emh Physicians Clinic, Iowa Falls, IA 50126 Phone: 641-648-6491 Fax: 641-648-7088 | |
Ellsworth Municipal Hospital Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 110 Rocksylvania Ave, Iowa Falls, IA 50126 Phone: 641-648-4631 Fax: 641-648-2850 |